2024 Poster Index
| Presenter Name | Poster Title |
| Yasir H. Abdelgadir, M.B.B.S. | Global Awareness of Membranous Glomerulonephritis Over Two Decades: A Trend Analysis |
| Amir Abdipour, M.D. | Low Grade B-Cell Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report |
| Aurangzeb Afzal, M.B.B.S. | Blind Spot in the Radar of MEST-C Score: Type and Severity of Tubulointerstitial Nephritis in IgA Nephropathy |
| Aurangzeb Afzal, M.B.B.S. | IgM and C3 Deposition in Primary Focal Segmental Glomerulosclerosis (FSGS): A Clinical and Histopathological Spectrum |
| Nehaal Ahmed M.D. | Severe Symptomatic Hypercalcemia Induced Acute Kidney Injury and Hypertension |
| Alexandra Allman, M.D. | When “Amphoterrible” Cannot be Blamed |
| Matt Baker, PharmD | Long-term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies |
| Bethany L. Boyle, M.D. | A Curious Case of Renal Cysts |
| Andrew Carrel, Ph.D. | Efficacy of 12-week pegcetacoplan in kidney transplant recipients with recurrent C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN) |
| Melanie Corsten | Rhabdomyolysis in Diabetic Emergencies: A Rare Complication Highlighting the Necessity of Prompt Creatine Kinase Monitoring |
| Aimme Cortes | Polycystic Kidney Disease: An Analysis of Global Google Search Trends from 2004-2023 |
| Aimme Cortes | Social Listening as a Tool for Estimating Public Awareness of Chronic Kidney Disease |
| William Cortés-Figueroa, M.D. | Case of a young male patient who developed autoimmune vasculitis leading to severe bleeding along with impending renal failure |
| Joshua Daum, M.D., M.S. | Clear as "Budd": A Puzzling Case of IgA Nephropathy in the setting of Budd-Chiari Syndrome |
| Matthew Ross D'Costa, M.D. | Humoral Immunity in Kidney Transplant Recipients Before and After COVID-19 infection |
| Victor Sebastian Arruarana, M.D. | The effect of dietary protein consumption on renal function in adult patients with chronic kidney disease: A Systematic Review and Meta-analysis |
| Oscar A. Garcia Valencia, M.D. | Improving Health Equity: ChatGPT's Translation of Kidney Transplant FAQs for Spanish-Speaking Hispanic Community |
| Briauna Hawthorne, M.D. | A Case Study of a Patient with Cobalt and Chromium Toxicity Following Hip Replacement |
| Larry Palmisano, PharmD, MBA, RPh | Safety and Efficacy of Avacopan in Patients 65 Years and Older with ANCA-Associated Vasculitis |
| Priscilla Koirala, M.D. | Intersecting Pathologies: Co-Occurrence of Alport’s Syndrome and Dense Deposit Disease |
| Rebecca Ann Kurian, M.D. | A Case of Immunotactoid Glomerulonephritis in a Patient with Autoimmune Liver Disease after Septic Shock |
| Caroline Bergeron Ledet, M.D. | Haptens Happen: A Case of Pigment Nephropathy Secondary to Intravenous Famotidine |
| Yun Liang, M.D., M.P.H. | Severe Lymphopenia and Increased Memory and Senescent T cells at 3 Years After Transplantation Correlate with Mortality |
| Poemlarp Mekraksakit, M.D. | Parathyroid Adenoma in a Patient with Gitelman Syndrome and Hypercalcemia |
| Poemlarp Mekraksakit, M.D. | Acute Interstitial Nephritis Induced by Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP) – Unveiling a Novel Suspect |
| Jonathan Mina, M.D. | Addressing the Fluid Resuscitation Conundrum in Sepsis among End Stage Renal Disease Patients: An In-Depth Systematic Review and Meta-Analysis |
| Jordan S. Nunnelee, M.D. | Concurrence of Chronic Kidney Disease and Monoclonal Gammopathy: The Importance of Recognizing the Diagnosis of MGRS |
| Steven Pham, D.O., MBA | Acarbose unveiled: A breakthrough in postprandial hypotension treatment |
| Yeshwanter Radhakrishnan, M.B.B.S. | A case of membranous nephropathy secondary to chronic lymphocytic leukemia |
| Zeyad Rifai, D.O. | Eculizumab Therapy in SARS-CoV-2 Induced CM-TMA: A Case Report on Renal Recovery |
| Lauren Dwyer, M.P.H., MBA, RD | Sparsentan, a Novel Nonimmunosuppressive Therapy for Patients With Immunoglobulin A Nephropathy (IgAN): Pivotal Phase 3 PROTECT Trial Data |
| Anna Schubart, Ph.D. | Iptacopan (LNP023) Inhibits Activity of Factor B (FB) Mutants Identified in Patients With Atypical Hemolytic Uremic Syndrome (aHUS) |
| Mohammad Salman Sheikh, M.D. | Navigating Lithium Pill Identification with ChatGPT-4 Vision: Implications for Nephrology |
| Mohammad Salman Sheikh, M.D. | Evaluation of ChatGPT-4’s Efficacy in Identifying Kidney Health Medications from Self-Captured Pill Images: A Pilot Study |
| Zafar Siddiqui, M.D. | A Unique Case Study of Type I Cryoglobulinemia Mediated Renal Injury |
| Nickolas Steinauer, M.D., Ph.D | Acute interstitial nephritis as a rare manifestation of VEXAS syndrome |
| Andikan Effiong Udoh, M.D. | A Tale of Two Kidneys |
| Paavana Varanasi, M.D. | Unraveling MGRS Challenges Amidst CKD Risks |
| Samiddhi D Weerasiri, M.D. | A Case of 5-Oxoprolinemia |
Thank you for your interest in submitting an abstract for consideration of a poster at the Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2024 in Coronado, California. Please complete the fields below and click submit at the end of the form. You should receive a confirmation e-mail after you click submit. Submissions are closed.
Accepted abstract recipients will be chosen from all abstracts received by Friday, January 12, 2024 submission deadline. Notification of acceptance can occur within 1-2 weeks of submission prior to this deadline and no later than 1 week after this deadline.
Application:
- All fields are required, omitting this information may lead to rejection of your abstract. Abstract presenters are required to attend the full meeting.
- Additional authors cannot be added after the abstract has been submitted.
- NO graphs or references allowed - text only please.
- Submission of an abstract does not automatically register you for the course.
Abstracts can be submitted in the following formats:
- Research Abstracts: All types of nephrology-related research are eligible for submission and should address scientific questions, detail clinical observations, or contain preliminary scientific data. Also research into systems-based practice innovation or improvements will be reviewed for acceptance.
- Clinical Cases: These may include challenging clinical cases encountered in practice (ie., case reports) of those encountered in clinical practice. Case reports must include uniqueness of the case, clinical findings presented, outcomes documented, and "take-away" lessons (teaching points).
Abstract Eligibility:
Original abstracts that either have or have not been presented at other meetings will be considered for the conference. Abstracts based upon published papers will also be considered.
Number of Entries:
A participant may be the primary author on no more than two abstracts, however, he or she may be a contributing author on any number of abstracts.
Notification of Results:
Accepted abstracts will be notified by email. All primary authors will be notified by email no later than 2 weeks following their submission, if their submission has been selected for the poster session and details regarding poster set-up will follow. Accepted abstract recipients must still register for the meeting to attend.
Inquiries:
For further information, contact Iwona Bukato at flacmeabstracts@mayo.edu.